# Success of External Cephalic Version Study

> **NCT03106753** · PHASE4 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 34 (actual)

## Conditions studied

- External Cephalic Version

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Terbutaline

## Key facts

- **NCT ID:** NCT03106753
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-12
- **Primary completion:** 2018-05-05
- **Final completion:** 2018-05-05
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Interim analysis to assess concern for spinal anesthesia and increased cesarean delivery rate.
- **Last updated:** 2020-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03106753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03106753, "Success of External Cephalic Version Study". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03106753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*